Re:A human monoclonal 1 antibody blocking SARS-CoV-2 infection
by delhanty on Saturday March 14, 2020 @07:16AM
(#22574495)
It's not just live or die you know. Reduced quality of life is a possible out come too:
>Similar to patients with SARS-CoV and MERS-CoV, some patients with 2019-nCoV develop acute respiratory distress syndrome (ARDS) with characteristic pulmonary ground glass changes on imaging. In most moribund patients, 2019-nCoV infection is also associated with a cytokine storm, ... in those who survive intensive care, these aberrant and excessive immune responses lead to long-term lung damage and fibrosis, causing functional disability and reduced quality of life.
Re:A human monoclonal 1 antibody blocking SARS-CoV-2 infection
by forkexec on Saturday March 14, 2020 @07:30AM
(#22574538)
Yep. Both SARS viruses can damage the lungs. And short of lung transplantation and likely a lifetime of anti-rejection medications, lost lung function doesn't return.
>Similar to patients with SARS-CoV and MERS-CoV, some patients with 2019-nCoV develop acute respiratory distress syndrome (ARDS) with characteristic pulmonary ground glass changes on imaging. In most moribund patients, 2019-nCoV infection is also associated with a cytokine storm, ... in those who survive intensive care, these aberrant and excessive immune responses lead to long-term lung damage and fibrosis, causing functional disability and reduced quality of life.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6...